RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
批准号:
10469673
负责人:
Mary C Nakamura
金额:
$80.74万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-09-21 至 2026-08-31
关键词:
AddressAreaAutomobile DrivingBioinformaticsBiologyCaliforniaCellsClinicalClinical DataClinical InformaticsClinical ResearchClinical TreatmentCollaborationsComputational BiologyConsultationsDataDatabasesDevelopmentDiagnosisDiagnosticDiseaseEducational workshopElectronic Health RecordEnsureEnvironmentEtiologyEvolutionFundingFutureGenomicsGoalsGrantHeterogeneityImmunologyImmunophenotypingIndividualInfrastructureInstitutesInterdisciplinary StudyKnowledgeLeadershipMentorsMethodologyMethodsModalityMolecularPathway interactionsPatientsPopulationPrognosisQuality ControlRecording of previous eventsResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesRheumatismRheumatologyRunningSamplingSan FranciscoScienceSelection for TreatmentsSeriesServicesTalentsTechnologyTrainingTranslational ResearchUniversitiesWorkaccurate diagnosisautoimmune rheumatologic diseasebaseclinical careclinical heterogeneityclinical phenotypecohortdata disseminationdata resourcedata sharingdesigndisorder subtypegenomic dataimprovedinnovationinterdisciplinary approachinterestmembermolecular phenotypemultiple omicsnew technologynext generationnovelnovel therapeuticsprecision medicineprogramsranpirnaseresearch studysingle cell sequencingsymposiumtranscriptomicstranslational scientisttreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
PREMIER, the UCSF Precision Medicine in Rheumatology Center (P30), provides critically important
resources and expertise to enable cutting-edge research to advance precision medicine in the rheumatic
diseases. PREMIER brings together clinical expertise, defined patient cohorts, state-of-the-art
immunophenotyping and genomic technologies with experts in bioinformatics and integrative analyses. This
infrastructure facilitates collaborative studies that can integrate the large amounts of clinical and molecular data
needed to gain a more fundamental understanding of the biology driving the heterogeneity of clinical phenotypes
and treatment responses among individuals with rheumatic disease. PREMIER seeks to lower the barriers to
pursuing rheumatology research by providing access to relevant resources along with the expertise to use them
appropriately.
Our Center includes three Resource Cores that will each provide consultation to guide investigators in study
design, analysis, and access to significant expertise and assistance in forming the collaborations needed. The
Clinical Data and Informatics Core (CDI), directed by Dr. Jinoos Yazdany, will provide clinical research and
informatics services including access to large rheumatic diseases databases, biospecimens and curation of
electronic health record data for research discovery; the Genomic Technology Core (GT), co-directed by Drs.
Jimmie Ye and Walter Eckalbar, will develop novel genomic technologies and institute specialized workflows
and analytic pathways designed for the study of rheumatic diseases; and the Integrative Bioinformatics Core
(IB), co-directed by Drs. Marina Sirota and Gabriela Fragiadakis, will address investigator needs for advanced
bioinformatics expertise, particularly with regard to single cell analytics, multi-omic integrative analysis, and use
of publicly available data. PREMIER’s Administrative Core is led by Dr. Mary Nakamura (Director) and Dr.
Jinoos Yazdany (Associate Director) and provides leadership and organizational oversight to the Center. The
Core includes a significant enrichment program involving seminars, an annual symposium, workshops led by the
Resource Cores, a mentoring program, and a grant program including Development and Feasibility Pilot grants
and Core Usage Grants. PREMIER leverages a number of significant UCSF and divisional resources that are
highly synergistic with the services offered in PREMIER Resource Cores.
Given our track record and deep commitment to innovation, PREMIER is poised to attract new
investigators and further advance rheumatology research towards the ultimate goal of improving
diagnosis and treatment of rheumatic disease through the detailed elucidation of underlying disease
mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10469674
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Administrative Core
-
批准号:10281471
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
-
批准号:10685559
-
项目类别:
-
资助金额:$80.74万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY
-
批准号:10281470
-
项目类别:
-
资助金额:$80.74万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Administrative Core
-
批准号:10685560
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
Resource-based Center for the Advancement of Precision Medicine in Rheumatology
-
批准号:10007596
-
项目类别:
-
资助金额:$72.17万
-
财政年份:2016
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:8397538
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:7797802
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:8195894
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
DAP12 and ITAM-signals in Osteoclastogenesis
-
批准号:7906050
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Mary C Nakamura
-
依托单位:
Using VEGF expression in inflammatory arthritis to induce targeted apoptosis
-
批准号:7667470
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2008
-
负责人:Mary C Nakamura
-
依托单位:
Using VEGF expression in inflammatory arthritis to induce targeted apoptosis
-
批准号:7509772
-
项目类别:
-
资助金额:$17.09万
-
财政年份:2008
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:6819863
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:7281156
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:7476480
-
项目类别:
-
资助金额:$27.9万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:7114316
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
DAP-12 ASSOCIATED RECEPTORS IN OSTEOCLASTS
-
批准号:6929003
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2004
-
负责人:Mary C Nakamura
-
依托单位:
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
-
批准号:2077491
-
项目类别:
-
资助金额:$7.61万
-
财政年份:1994
-
负责人:Mary C Nakamura
-
依托单位:
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
-
批准号:2732785
-
项目类别:
-
资助金额:$8.91万
-
财政年份:1994
-
负责人:Mary C Nakamura
-
依托单位:
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLS
-
批准号:2077492
-
项目类别:
-
资助金额:$7.67万
-
财政年份:1994
-
负责人:Mary C Nakamura
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: